About
Catheter-guided infusion systems
Areas of Focus
Categories
Drug Delivery DeviceBiotech
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
10
As Collaborator
0
Total Enrollment
1,076
By Phase
PHASE3: 1PHASE2: 6NA: 1PHASE4: 1
By Status
RECRUITING: 3UNKNOWN: 3COMPLETED: 3TERMINATED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT04433572Lead Sponsor
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
PHASE3Recruiting
250 participants
Started: Jul 30, 2025 · Completed: Aug 1, 2032
NCT04858776Lead Sponsor
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT
PHASE2Recruiting
60 participants
Started: Aug 8, 2022 · Completed: Dec 31, 2026
NCT04862468Lead Sponsor
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
PHASE2Recruiting
80 participants
Started: Oct 29, 2021 · Completed: Feb 1, 2028
NCT03942601Lead Sponsor
Temsirolimus Alone or Paired With Dexamethasone Delivered to the Adventitia to eNhance Clinical Efficacy After Femoropopliteal Revascularization
PHASE2Terminated
10 participants
Started: Oct 1, 2019 · Completed: Apr 30, 2021
NCT02908035Lead Sponsor
Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
PHASE2Unknown
100 participants
Started: Mar 3, 2017 · Completed: Sep 30, 2021
Locations (1)
Headquarters
San Leandro, CA, United States
Map
Loading map...